A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, Alternative Names: Semenogelin I control peptide, Semenogelin I antibody Blocking Peptide, Anti-Semenogelin I Blocking Peptide, MGC14719 Blocking Peptide, SEMG Blocking Peptide, SGI Blocking Peptide, SEMG1 Blocking Peptide
SEMG1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SEMG1
(Semenogelin I (SEMG1))
Hintergrund
SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly having a separate function. The proteolysis process breaks down the gel matrix and allows the spermatozoa to move more freely.